Epithalon (also known as Epithalon or Epithalone) is a tetrapeptide consisting of Ala-Glu-Asp-Gly (AEDG) amino acids that has demonstrated significant cardiovascular benefits through multiple mechanisms. Epithalon is a therapeutic tetrapeptide consisting of the amino acids alanine, glutamic acid, aspartic acid, and glycine. This remarkable peptide, originally developed at the St. Petersburg Institute of Bioregulation and Gerontology, offers profound cardioprotective properties that extend far beyond its primary role as a telomerase activator.
The connection between telomere health and cardiovascular function is well-established in scientific literature. In 2004, the American Heart Association described telomere dysfunction as an “important factor in the pathogenesis of hypertension, atherosclerosis, and heart failure,” a claim that has been borne out in research since.
Telomere attrition is linked not just to aging, but to cardiovascular disease, immune decline, type 2 diabetes, and neurodegeneration. By supporting telomere length through telomerase activation, Epithalon addresses one of the fundamental mechanisms underlying cardiovascular aging.
Long-term clinical studies have demonstrated remarkable cardiovascular outcomes with Epithalon treatment. Epithalamin treatment resulted in a 2-fold lower rate of cardiovascular disease-specific mortality.
A 3-year (15-year total) follow-up study reported that epithalamin treatment “prevented age-associated impairment of physical endurance, normalized circadian rhythm of melatonin production and carbohydrate and lipid metabolism.”
The results found that the peptide improved cardiac health and decreased the cardiac mortality by two-fold as compared to the control. Moreover, one study showed that epithalon improved lipid profile and mean arterial pressure in female subjects.
Research has specifically examined Epithalon’s effects on blood pressure control. In a 2008 study, the authors investigate the effect of a pineal gland peptide preparation on the diurnal profile of arterial pressure in middle-aged and elderly women who have ischemic heart disease and arterial hypertension. The study likely explores how this peptide preparation influences blood pressure fluctuations throughout the day and night in individuals with these cardiovascular conditions. The research may provide insights into the potential therapeutic applications of the pineal gland peptide in managing blood pressure in this specific patient population.
Epithalon’s influence on cardiovascular health extends through its regulation of melatonin production. Melatonin contributes to blood pressure and autonomic cardiovascular regulation, enhancement of immune function, and reduction of inflammation in the gastrointestinal tract.
The correlation between reduced melatonin levels and pathologies such as Alzheimer’s onset, menopause severity, and cardiovascular disorders underscores the importance of Epithalon’s melatonin-regulating effects for heart health.
Epithalon is a synthetic tetrapeptide that has been shown to induce telomerase activity and telomere elongation in human somatic cells. It has also been shown to suppress CCl11 and HMGB1 genes, which are markers associated with aging and neurological, cardiovascular, and immune diseases.
Researchers conducted a 15-year follow-up with 39 coronary patients that had received regular courses of epithalamin and basic therapy and compared them with a control group of 40 coronary patients that had received the therapy alone.
The obtained results convincingly showed the ability of the bioregulators to normalize the basic functions of the human organism, i.e. to improve the indices of cardiovascular, endocrine, immune and nervous systems, homeostasis and metabolism. Homeostasis restoration was accompanied by a 2.0-2.4-fold decrease in acute respiratory disease incidence, reduced incidence of the clinical manifestations of ischemic heart disease, hypertension disease.
In 2003, a multi-year study published in Neuroendocrinology Letters found that epithalamin could “normalize the basic functions of the human organism,” potentially extending lifespan by improving cardiovascular, endocrine, immune, and nervous function, as well as homeostasis and metabolism.
